Healing antibodies may trigger systemic inflammation through circulating immune complexes
In skin explants sharing medium, donor-matched immune cells and active complement, healing antibodies may cause body-wide inflammation. Confirmed antibody removal and restoration must reproduce the predicted loss and return of remote inflammation and local healing benefits; otherwise the mechanism is refuted.
Stage of verification
- Hypothesis published2026-09-25
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Antibody
Tissue-binding antibodies
Antibodies that bind antigens in tissue
Where this hypothesis actsSkin explants sharing circulating medium with autologous immune cells and active complement
Hypotheses on this target 1
Lower level
Protection from degradation
Synthesis suppression
Neutralisation
Accelerated excretion1
What is proposed
Accelerated excretion
Selectively deplete tissue-binding antibodies to test their role in systemic inflammation
With whatRemoval from a body fluid
HowSelectively remove the antibodies, then add back purified original antibodies; compare with fragments lacking the Fc region
Possible result
Possible reduction in distant inflammatory activation, accompanied by slower local repair
From the recordИзбирательное удаление этих антител должно снижать удалённую воспалительную активацию, одновременно замедляя локальное восстановление
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Repairing several patches of skin at once might affect the body beyond the treated areas. The unexpected proposal is that the same antibodies that help local healing could also produce inflammation elsewhere, with the strongest effect at an intermediate load rather than the largest load. This is a hypothesis generated by the pipeline, not a measured result.
- Several healing skin areas are proposed to release tissue targets into the shared circulation.
- Antibodies that help local repair are proposed to bind those targets and assemble circulating clusters.
- Suitable target-to-antibody proportions are proposed to produce clusters with multiple binding sites that activate complement and bring activating Fc receptors together.
- Those clusters are proposed to keep immune cells active beyond the healing sites.
- As tissue targets become excessive relative to antibodies, the response is predicted to fall from its intermediate peak rather than keep increasing.
Paper pieces and clips can make a connected bundle when their numbers suit each other. Adding more paper without adding clips need not make the bundle more connected.
Where the picture breaks: Antibodies and tissue targets have specific binding arrangements, and their clusters must activate living immune systems. The picture explains why proportions could matter; it does not establish the proposed peak or identify the proportions that would produce it.
- Master questionstep 01 of 04
A therapy would aim to restore the functional condition of middle-aged human skin to that of young people.
Rests on: The goal itself sets younger skin function as the intended outcome.
Stated in the chain - Goal pillarstep 02 of 04
Repeated rounds of skin repair may encounter limits created by the repair process itself.
Rests on: The move from restoring younger skin function to repeated repair requires treating repeated repair and its limits as relevant to that goal.
AssumptionThe chain assumes that repeated repair is a route toward the desired skin function and that repair-induced limits matter to its success. The master question does not establish either premise.
- Gap questionstep 03 of 04
Several healing areas might release inflammation-promoting substances faster than the body can remove them, leaving effects throughout the body. Accounting for how much enters, remains and leaves might then predict safe overlap between repair cycles better than total treated area.
Rests on: The preceding stage identifies limits during repeated repair but does not identify the removal of inflammatory substances as the limiting process.
LeapThe supplied chain and sources do not establish that simultaneous skin repair overwhelms removal, or that accounting for production and removal predicts safe overlap better than treated area. Those are the missing connections the question seeks to investigate.
- Hypothesisstep 04 of 04
Antibodies that help local healing are proposed to bind antigens, tissue material recognized by those antibodies, and form circulating immune complexes, clusters of antibodies and their bound targets. At suitable proportions, the clusters would activate complement, a group of cooperating immune proteins, and bring together activating Fc receptors, immune-cell surface proteins that recognize the antibody tail called the fragment crystallizable region. The proposal predicts that inflammation could peak at an intermediate total load and decrease when antigen is in excess.
Rests on: The preceding question supplies the problem of effects beyond simultaneously healing sites. The endpoint supplies its own proposed explanation: the proportions of antibody and tissue targets determine whether clusters can activate immune cells. It offers a different causal route from overwhelmed removal.
Stated in the chain
What is carried, and what is not. Two screened sources support separate components in other settings: S4, Nature Communications (2024), reports that a particular antibody treatment improved wound closure in skin maintained outside the body from breast cancer survivors after radiation treatment, but does not connect that benefit to circulating clusters or inflammation elsewhere; S8, Blood (2021), reports that very large antibody–target clusters interacted with the complement protein C1q and activated complement in heparin-induced thrombocytopenia, a condition involving low blood platelets associated with the drug heparin, but does not establish these events during skin healing. Neither source establishes the proposed sequence end to end, the intermediate peak, or a safe schedule for repeated treatment.S4S8
Where the reasoning is carried by something unstated · 2
- Goal pillar. The chain assumes that repeated repair is a route toward the desired skin function and that repair-induced limits matter to its success. The master question does not establish either premise.
- Gap question. The supplied chain and sources do not establish that simultaneous skin repair overwhelms removal, or that accounting for production and removal predicts safe overlap better than treated area. Those are the missing connections the question seeks to investigate. Establish the missing link before relying on this step.
How a result here could mislead · 3
- A rise and fall in immune-cell activity as antibody concentration changes could be credited to cluster proportions even if the amount of released tissue target also changes because healing changes. Antibody concentration alone does not establish the target-to-antibody ratio. What closes it: Measure released tissue targets and available antibodies alongside cluster size, C1q binding, complement activation and local repair. The predicted peak must be related to measured proportions and cluster properties, rather than merely to the amount of antibody added.
- A fall in remote inflammation after antibody removal could reflect unintended changes caused by the removal procedure. Likewise, failure of antibody fragments without the tail to restore inflammation could reflect weaker target binding rather than loss of the proposed immune-activating function. What closes it: A matched control must undergo the same processing without removal of the target antibodies, and removal and restoration must be verified. The specified comparison with tail-free fragments requires comparable target binding; the intact antibodies must also have independently established healing benefit.
- An effect in skin explants, pieces of skin maintained outside the body, could be read as defeating the rival explanation based on competing nerve signals. The specified shared-medium system does not include the central sensory circuits, brain and spinal-cord networks that process incoming signals, required by that rival. What closes it: Interpret the system as testing whether the antibody route can operate under its specified conditions. Distinguishing its contribution from the nerve route in a body requires a setting that contains both routes and measurements or interventions that separate them.
What would make this wrong. The proposal identifies failure of its removal-and-restoration sequence, despite confirmed antibody removal and restoration, as a falsifying result. In particular, if antibodies with independently confirmed healing benefit were removed and then restored without the predicted corresponding loss and return of remote inflammatory activation, the claimed connection between local healing benefit and inflammation elsewhere would fail. Restoration of the remote effect by tail-free fragments with comparable target binding would also contradict the specified requirement for the antibody tail.
What it would change. If the mechanism held, planning repeated skin repair would need to account for the proportions and immune-activating properties of antibody–target clusters, rather than assuming that more treated area always means a larger response. That would identify a possible constraint on attempts to restore younger skin function, but would not show that repeated repair achieves that goal. The proposed outside-the-body system would establish neither how often complications occur in people nor the safety of a ten-year regimen; the intended measure called SPV_10 is not defined in the supplied material.
Sources read · 7
An optimized flow cytometry panel for classifying macrophage polarization. · Journal of immunological methods · 2022
“Macrophages are scavenger cells and a fundamental part of innate and adaptive immune responses, and they are important in wound repair and tissue remodeling.”
Does not settle: Источник не исследует циркулирующие иммунные комплексы, соотношения антигенов и антител, активацию комплемента или Fc-рецепторов, системное воспаление при одновременном заживлении нескольких участков либо опасный диапазон нагрузок.
Regulation of wound healing by growth factors and cytokines. · Physiological reviews · 2003
“Initial approaches at addressing this question focused on the expression analysis of various growth factors, cytokines, and their receptors in different wound models, with first functional data being obtained by applying neutralizing antibodies to wounds.”
Does not settle: Источник не устанавливает образование циркулирующих иммунных комплексов при заживлении, их системное воспалительное действие, роль соотношения антигена и антитела, активацию комплемента или Fc-рецепторов, а также зависимость последействия от суммарной нагрузки.
Epigenetic memory of radiotherapy in dermal fibroblasts impairs wound repair capacity in cancer survivors. · Nature communications · 2024
“Treatment with anti-THBS1 antibodies promotes ex vivo wound closure in RT + skin from breast cancer survivors.”
Does not settle: Источник описывает местное заживление ex vivo после применения антител к THBS1. Циркулирующие иммунные комплексы, системное воспаление, соотношение антигенов и антител, активация комплемента и Fc-рецепторов, а также эффект одновременного восстановления нескольких участков в тексте не исследуются.
Complement and immune complex diseases. · Australian and New Zealand journal of medicine · 1986
“There has been definition of the roles of individual components in modulation of immune complex formation, the deposition of which leads to tissue injury in the autoimmune connective tissue diseases.”
Does not settle: Источник не устанавливает связь антител, способствующих заживлению, с системным воспалением при восстановлении нескольких участков. Он не рассматривает соотношения антигенов и антител, циркулирующие комплексы, активацию Fc-рецепторов, избыток антигена, дозы, расписания или SPV_10.
Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes. · Blood · 2021
“We observed that HIT ULICs physically interact with C1q in buffer and plasma, activate complement via the classical pathway, promote codeposition of IgG and C3 complement fragments (C3c) on neutrophil and monocyte cell surfaces.”
Does not settle: Источник описывает иммунные комплексы при гепарин-индуцированной тромбоцитопении. Он не устанавливает, что антитела, способствующие заживлению, образуют такие комплексы при восстановлении нескольких участков, не определяет опасный диапазон соотношений антигена и антител, влияние избытка антигена или последствия для SPV_10.
Humanised monoclonal antibodies neutralise pertussis toxin by receptor blockade and reduced retrograde trafficking. · Cellular microbiology · 2018
“Both antibodies, either individually or as a cocktail, form multivalent complexes with soluble PTx that bind the FcγRIIb receptor more tightly than antibody alone, suggesting that the antibodies may accelerate PTx clearance via immune complex formation.”
Does not settle: This source does not establish systemic inflammation, healing-associated tissue antigens, multiple simultaneous healing sites, antigen-antibody ratio effects, complement activation, activating Fc-receptor clustering, or an effect of antigen excess.
Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1). · Clinical and experimental immunology · 1991
“C3b-coated immune complexes adhere to the complement receptor 1 (CR1, CD35) on human erythrocytes.”
Does not settle: Источник описывает связывание C3b-покрытых иммунных комплексов с CR1 эритроцитов человека. Он не устанавливает связь антител, способствующих заживлению, с системным воспалением, влияние одновременного заживления нескольких участков, опасные соотношения антигена и антител, активацию комплемента или Fc-рецепторов, промежуточный максимум эффекта либо динамику SPV_10.
The gap this hypothesis explains
Nothing is known here: the question has not been asked of this system.
Does overlapping skin repair overwhelm inflammatory-signal removal, and does tracking amounts predict safety better than treated area?
Original wording · exactly as the pipeline generated it
Возникает ли системное последействие одновременной регенерации участков кожи из-за насыщения удаления воспалительных медиаторов, и предсказывает ли баланс массы безопасное перекрытие циклов точнее суммарной площади лечения?
What this question is asking
The question concerns whether repairing several skin areas at overlapping times leaves effects elsewhere in the body after treatment. It asks whether inflammatory signals from those areas arrive faster than the body can remove them, allowing signals to accumulate between treatment cycles. It then asks whether accounting for signal production, removal and remaining amounts predicts safe overlap more accurately than adding up the treated skin area, including any contribution from processes outside the skin. The framing assumes that spacing treatments and lymphatic drainage are relevant to this problem, and sets a requirement that effects subside within specified days or weeks without residual accumulation; the supplied evidence establishes neither that timeframe nor a safe treatment schedule.
- Skin repair and regeneration
- Skin repair is the process of healing damaged skin. Regeneration implies restoration of tissue; the supplied wound-healing findings do not establish restoration to the functional state of young skin.
- Inflammatory signals or mediators
- A class of substances involved in coordinating inflammation, rather than one substance with one removal rate. The question does not specify which signals would be measured or counted.
- Inflammation
- A tissue response involved in injury and healing. The supplied material describes both a supporting role during healing and problems associated with persistence, so its presence alone does not define harm.
- Systemic effects
- Effects involving the body beyond the treated skin area. Here, persistent systemic effects mean effects continuing after treatment or into another treatment cycle; the input specifies no particular measurement.
- Removal capacity and saturation
- Removal capacity is how much of a signal can be removed over time. Saturation is the proposed condition in which removal cannot keep pace with additional input; it is not demonstrated by the supplied sources.
- Mass balance
- An accounting of how an amount changes through what enters or is produced and what leaves or is removed. Here it is a proposed way to track inflammatory signals remaining over time, not a validated safety model.
- Treatment-cycle overlap
- Timing in which another treatment or repair period begins while an earlier one is still having effects. It differs from the normal overlap of healing stages described within a wound.
- Total treated area
- The combined surface area of skin receiving treatment. It describes treatment extent but does not itself measure inflammatory-signal production or removal.
- Lymphatic drainage
- Movement of fluid away from tissues through the lymphatic system. Manual lymphatic drainage is a hands-on treatment intended to assist that movement; a change in drainage does not by itself quantify inflammatory-signal removal.
- Macrophages
- Immune cells involved in inflammation and tissue repair. The inflammation-promoting description in S6 identifies a functional state, not a permanently separate cell type.
- Fibroblasts
- Cells involved in making and maintaining tissue's supporting material. S6 reports that they support movement of skin-surface cells during healing.
- Keratinocytes
- Cells that form the skin's outer covering. Their movement helps restore coverage over a wound.
- Neutrophils
- Immune cells involved in the inflammatory response. S9 discusses their timely removal from the wound environment, which is a different measurement from removal of signal molecules.
Spacing skin-repair cycles and lymphatic removal provide a basis for a schedule in which systemic effects resolve within days or weeks without residual accumulation, although the quantitative limit of mediator removal remains unknown.
The lymphatic system drains fluid from tissues, while treatment spacing determines how much repair happens at the same time. The framing treats these as relevant controls on inflammatory signals remaining elsewhere in the body between treatments. If that relationship were established, it could connect treatment timing to a measurable limit on accumulation.
The supplied search results do not establish this scheduling premise, a removal-capacity limit or the required recovery timeframe. S4 presents improved lymphatic drainage as part of the rationale for a wound-treatment study, rather than measuring whole-body removal of inflammatory signals. S5 reports that small changes in lymphatic function were not related to symptoms or signs in women after breast cancer surgery. Neither source establishes the proposed relationship for overlapping skin repair, and the internal references mentioned in the gap detail have no supplied source content. This absence of support does not establish that the premise is false.S4S5
The same question asked without the part nothing read establishes:
- Does overlapping repair of several skin areas produce persistent effects elsewhere in the body, and are those effects associated with inflammatory-signal production exceeding removal?
- Does accounting for inflammatory-signal production and removal predict safe overlap of skin-repair cycles more accurately than total treated area?
- Removal is overwhelmed; tracking amounts predicts better Under the proposed mechanism, overlapping repair would make signal input exceed removal, leaving amounts that persist into later cycles. If accounting for those amounts also predicts safety better, treated area alone would omit information needed to distinguish safer from less safe overlap.
- Removal is overwhelmed; predictive advantage is absent Accumulation could explain persistent effects without making the proposed calculation a better safety predictor. Establishing the mechanism would therefore not establish that the calculation improves scheduling compared with treated area.
- Persistent effects occur without overwhelmed removal Effects elsewhere in the body could persist while the proposed removal bottleneck remains unestablished. A calculation built around that bottleneck would then lack a demonstrated explanation for the persistence, and its predictive value would remain a separate question.
- No persistent effects are detected There would be no observed persistent effect for overloaded removal to explain under the conditions assessed. That outcome alone would establish neither safety under other treatment conditions nor a predictive advantage for accounting for signal amounts.
The proposed causal chain runs from overlapping skin repair to combined inflammatory-signal production, then potentially to insufficient removal, accumulation and persistent effects elsewhere in the body. Each connection would need support before this chain could explain treatment safety. If the chain holds, treated area alone could miss differences in timing, signal production or removal. If it does not hold, attributing persistent effects to overloaded removal could misidentify their cause, and a calculation based on that mechanism could give misleading reassurance.
Разнесение участков по времени RL-3 и лимфатические механизмы RL-1 не устанавливают количественный предел общего удаления медиаторов.
Системный ответ затухает за установленные дни или недели без остаточного накопления при допустимой площади и частоте восстановления.
Отсутствует проверенная зависимость системного последействия от площади, перекрытия циклов и внекожной нагрузки, позволяющая обосновать выполнимое расписание.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Проверяемая гипотеза: антитела, способствующие локальному заживлению, при одновременном восстановлении нескольких участков образуют с высвобождаемыми тканевыми антигенами циркулирующие иммунные комплексы, которые запускают системное воспаление. Ключевое условие представляет собой соотношение антигенов и антител, позволяющее многовалентным комплексам активировать комплемент и объединять активирующие Fc-рецепторы иммунных клеток. Поэтому системное последействие может достигать максимума при промежуточной суммарной нагрузке и уменьшаться при избытке антигена. Субстрат последействия составляют комплексы и продолжающаяся активация ими иммунных клеток. Выявление опасного диапазона соотношений позволит проверять расписания, направленные на стабилизацию SPV_10.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
В системе кожных эксплантатов с общей циркуляцией среды, аутологичными иммунными клетками и активным комплементом варьируют перекрытие одинаковых повреждений и концентрацию антител, связывающих повреждённую ткань. Гипотеза предсказывает немонотонную зависимость системного клеточного ответа от отношения антиген/антитело. Максимум должен совпадать с появлением крупных комплексов, связывающих C1q. Избирательное удаление этих антител должно снижать удалённую воспалительную активацию, одновременно замедляя локальное восстановление; добавление очищенных исходных антител должно возвращать оба эффекта. Фрагменты антител без Fc-области при сопоставимом связывании антигена не должны восстанавливать системный эффект. Отсутствие такой последовательности при подтверждённом удалении и восстановлении антител опровергнет предложенный механизм. Модель насыщаемого удаления медиатора дополнительно проверяют независимым измерением его исчезновения после прекращения поступления.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable response patterns, directional intervention effects, and an explicit rejection condition. The final sentence proposes a measurement but does not specify its expected outcome. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Доступны выделение тканесвязывающих антител, анализ распределения комплексов по размерам, определение связывания C1q, продуктов активации комплемента и ответа иммунных клеток. Наиболее сложная часть состоит в выделении антител, для которых отдельно подтверждена польза при заживлении. Эксплантатная система проверяет причинную цепочку; клиническую частоту системных осложнений и безопасность десятилетнего режима она не устанавливает.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
В системе кожных эксплантатов с общей циркуляцией среды, аутологичными иммунными клетками и активным комплементом варьируют перекрытие одинаковых повреждений и концентрацию антител, связывающих повреждённую ткань. Гипотеза предсказывает немонотонную зависимость системного клеточного ответа от отношения антиген/антитело. Максимум должен совпадать с появлением крупных комплексов, связывающих C1q. Избирательное удаление этих антител должно снижать удалённую воспалительную активацию, одновременно замедляя локальное восстановление; добавление очищенных исходных антител должно возвращать оба эффекта. Фрагменты антител без Fc-области при сопоставимом связывании антигена не должны восстанавливать системный эффект. Отсутствие такой последовательности при подтверждённом удалении и восстановлении антител опровергнет предложенный механизм. Модель насыщаемого удаления медиатора дополнительно проверяют независимым измерением его исчезновения после прекращения поступления.
- Rival 01 of 01What would separate them
The strongest skin nerve signal may sustain a body-wide response through competitive inhibition predicts: При одинаковой площади повреждения, сопоставимом поступлении медиаторов в кровь и одинаковой скорости их удаления системный вегетативный ответ должен зависеть преимущественно от максимального афферентного сигнала. Избирательное обратимое выключение чувствительной иннервации ведущего участка должно быстро снижать ответ до уровня второго по силе участка. Выключение более слабого участка должно давать существенно меньший эффект. После последовательного выключения всех участков ответ должен затухать без сохранения нервной памяти. Отсутствие зависимости от ранга участка при подтверждённой блокаде афферентного входа опровергнет правило выбора победителя. Снижение только субъективной боли без изменений вегетативных и воспалительных показателей также не подтвердит гипотезу.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
В экспериментальной работе антитела к повреждённой ткани улучшали кожное заживление. Это основание для проверки двойственной роли таких антител, но системное повреждение при перекрытии регенерации работа не доказывает. [Antibodies to wounded tissue enhance cutaneous wound healing](https://pmc.ncbi.nlm.nih.gov/articles/PMC2770685/).
Иммунология регенерации, учебная глава «Гуморальный иммунитет при заживлении ран и разрешении воспаления». Пересмотра потребовало бы положение о том, что нормальный гуморальный компонент успешного восстановления сам задаёт немонотонный предел допустимого перекрытия регенерации разных участков, даже при сохранённой скорости удаления растворимых медиаторов.
Одна и та же очищенная фракция антител ускоряет восстановление отдельного участка и воспроизводимо вызывает удалённую воспалительную активацию при определённом сочетании участков. Её удаление одновременно ухудшает местное заживление и улучшает системный исход. Увеличение антигенной нагрузки за пределы зоны максимума уменьшает системный ответ при неизменной кинетике удаления измеряемых цитокинов.
Статус HERETICAL предварительный. В выполненном поиске не найден обзор, утверждающий именно причинную цепочку «антитела с доказанной пользой для заживления → стехиометрический максимум системного повреждения при перекрытии регенерации». Существование иммунокомплексного воспаления общеизвестно, поэтому одной ссылки на этот механизм для признания гипотезы еретической недостаточно. Отсутствие публикаций во всей литературе не доказано.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.